FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 188 filers reported holding FATE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 4.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $561,176 | -66.4% | 98,452 | -40.5% | 0.05% | -73.8% |
| Q4 2022 | $1,670,026 | +93.7% | 165,513 | +330.5% | 0.20% | +191.0% |
| Q3 2022 | $862,000 | -62.6% | 38,451 | -58.6% | 0.07% | -64.6% |
| Q2 2022 | $2,304,000 | +821.6% | 92,987 | +2964.8% | 0.19% | +243.6% |
| Q1 2021 | $250,000 | -52.3% | 3,034 | -47.4% | 0.06% | -66.7% |
| Q4 2020 | $524,000 | – | 5,765 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |